Research article summary (published 20 Sep 2009):

Rosiglitazone and pioglitazone. Beware macular oedema.

Full Abstract

No abstract is available for this article. See 'Journal and Publication Information' further down the page for details that may assist you in locating this article in electronic or hard copy media. The 'Related articles' section also further down the page, where available, may show links to abstracts of articles covering similar topics.

Author information

Author/s: Lambley, Rosemary G (RG); Vahdani, Kaveh (K); Vahdani, Kave (K); Konstantinidis, Aris (A); Booth, Adam (A);

Journal and publication information

Publication Type: Comment; Letter

Journal: BMJ (Clinical research ed.) (BMJ), published in England. (Language: eng)

Reference: 2009-; vol 339 (issue ) : pp b3856

Dates: Created 2009/09/23; Completed 2009/09/28; Revised 2009/10/07;

PMID: 19773311, status: MEDLINE (last retrieval date: 10/7/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

Comments and Corrections

CommentOn: BMJ. 2009;339:b3076. (PMID: 19690344)

ErratumIn: BMJ. 2009;339. doi: 10.1136/bmj.b4044. (Note: Vahdani, Kave [corrected to Vahdani, Kaveh])

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Diabetic Angiopathies - chemically induced Diabetic Nephropathies - chemically induced Heart Failure - chemically induced Humans

Humans Hypoglycemic Agents - adverse effects Macular Edema - chemically induced Thiazolidinediones - adverse effects

Associated Chemicals: Hypoglycemic Agents (0) ; Thiazolidinediones (0) ; pioglitazone (111025-46-8) ; rosiglitazone (122320-73-4)

Related articles

These are the highest related articles currently in the database:

• Pioglitazone-induced heart failure despite normal left ventricular function. 13 Dec 2004
• Vision loss due to macular edema induced by rosiglitazone treatment of diabetes mellitus. 30 Aug 2005
• Retrospective analysis of rosiglitazone and macular oedema in patients with type 2 diabetes mellitus. 30 Dec 2007
• Diabetic macular edema associated with glitazone use. 29 Apr 2006
• Spontaneous resolution of diabetic macular oedema after discontinuation of thiazolidenediones. 29 Jun 2008
• Glitazones and macular oedema. 30 Jul 2006
• Pioglitazone use and heart failure in patients with type 2 diabetes and preexisting cardiovascular disease: data from the PROactive study (PROactive 08). 29 Jul 2007
• Thiazolidinediones and heart failure: a teleo-analysis. 27 May 2007
• Thiazolinediones and heart failure: the potential to precipitate irreversible cardiac dysfunction. 20 Feb 2007
• Do thiazolidinediones cause heart failure? A critical review. 30 Mar 2006

See 100+ related articles.

Related Article Map

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.